The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of changes in biomarkers with treatment with cabozantinib (Cabo) in metastatic castration-resistant prostate cancer (mCRPC): A post-hoc analysis of the 100mg nonrandomized expansion cohort of a randomized discontinuation trial.
 
Melania Pintilie
No Relationships to Disclose
 
Raya Leibowitz-Amit
No Relationships to Disclose
 
A. Douglas Laird
Employment - Exelixis
Stock and Other Ownership Interests - Exelixis
Patents, Royalties, Other Intellectual Property - Exelixis
 
Dana T. Aftab
Employment - Exelixis
Leadership - Exelixis
Stock and Other Ownership Interests - Exelixis
Patents, Royalties, Other Intellectual Property - Exelixis
 
Raanan Berger
No Relationships to Disclose
 
Kim N. Chi
No Relationships to Disclose
 
Anthony M. Joshua
No Relationships to Disclose